GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Yili Chuannig Biotechnology Co Ltd (SZSE:301301) » Definitions » Accounts Receivable

Yili Chuannig Biotechnology Co (SZSE:301301) Accounts Receivable : ¥821 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Yili Chuannig Biotechnology Co Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Yili Chuannig Biotechnology Co's accounts receivables for the quarter that ended in Mar. 2024 was ¥821 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Yili Chuannig Biotechnology Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 was 49.21.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Yili Chuannig Biotechnology Co's Net-Net Working Capital per share for the quarter that ended in Mar. 2024 was ¥-0.48.


Yili Chuannig Biotechnology Co Accounts Receivable Historical Data

The historical data trend for Yili Chuannig Biotechnology Co's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yili Chuannig Biotechnology Co Accounts Receivable Chart

Yili Chuannig Biotechnology Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Receivable
Get a 7-Day Free Trial 1,211.39 829.65 780.82 877.60 748.09

Yili Chuannig Biotechnology Co Quarterly Data
Dec18 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,021.31 931.87 907.00 748.09 821.45

Yili Chuannig Biotechnology Co Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


Yili Chuannig Biotechnology Co Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Yili Chuannig Biotechnology Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=821.45/1523.218*91
=49.21

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Yili Chuannig Biotechnology Co's accounts receivable are only considered to be worth 75% of book value:

Yili Chuannig Biotechnology Co's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2024 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(889.716+0.75 * 821.45+0.5 * 1360.666-3240.655
-0-12.883)/2227.16
=-0.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Yili Chuannig Biotechnology Co Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Yili Chuannig Biotechnology Co's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Yili Chuannig Biotechnology Co (SZSE:301301) Business Description

Traded in Other Exchanges
N/A
Address
No. 516, Almatua Village, Yining Park, Horgos Economic Development Zone, Xinjiang, Ili, CHN, 835000
Yili Chuannig Biotechnology Co Ltd adopts the most advanced and mature international biological fermentation, chemical extraction, enzymatic hydrolysis, control and energy saving, and environmental protection technology. The main products of the company include erythromycin thiocyanate, cephalosporin intermediates, penicillin intermediates, and crude ursodeoxycholic acid.

Yili Chuannig Biotechnology Co (SZSE:301301) Headlines

No Headlines